Format

Send to

Choose Destination
Nat Rev Drug Discov. 2004 Apr;3(4):340-51.

AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome.

Author information

1
Department of Medicine, Boston University School of Medicine and Diabetes Unit, Section of Endocrinology, Boston Medical Center, 715 Albany Street, Boston, Massachusetts 02118, USA. nruderman@medicine.bu.edu
PMID:
15060529
DOI:
10.1038/nrd1344
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center